Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES) [Phase 3]

View source ↗

Summary

A Phase III clinical trial is evaluating the efficacy and safety of benralizumab in patients with hypereosinophilic syndrome and is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypereosinophilic Syndrome

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Hypereosinophilic Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING